Publicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (29)

2024

  1. Recovery of Left Ventricular Function and Long-Term Outcomes in Patients With Takotsubo Syndrome

    Journal of the American College of Cardiology, Vol. 84, Núm. 13, pp. 1163-1174

2023

  1. Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2)

    Journal of Clinical Medicine, Vol. 12, Núm. 2

  2. Post-COVID-19 syndrome and diabetes mellitus: a propensity-matched analysis of the International HOPE-II COVID-19 Registry

    Frontiers in Endocrinology, Vol. 14

2022

  1. Chronic use of renin–angiotensin–aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis

    Medicina Clinica, Vol. 158, Núm. 7, pp. 315-323

  2. Clinical characteristics and prognosis of myocardial infarction with non-obstructive coronary arteries: A prospective single-center study

    Cardiology Journal, Vol. 29, Núm. 5, pp. 798-806

  3. Differences Between Takotsubo and the Working Diagnosis of Myocardial Infarction With Nonobstructive Coronary Arteries

    Frontiers in Cardiovascular Medicine, Vol. 9

  4. Erratum to “Takotsubo syndrome and cancer, clinical and prognostic implications, insights of RETAKO” [Med Clin (Barc). 2020;155(12):521-528] (Medicina Clinica (2020) 155(12) (521–528), (S0025775320301895), (10.1016/j.medcli.2020.01.033))

    Medicina Clinica

  5. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

  6. Transcatheter aortic valve replacement in obese patients: procedural vascular complications with the trans-femoral and trans-carotid access routes

    Interactive cardiovascular and thoracic surgery, Vol. 34, Núm. 6, pp. 982-989

2021

  1. Association between myocardial injury and prognosis of COVID-19 hospitalized patients, with or without heart disease. CARDIOVID registry

    Revista Espanola de Cardiologia, Vol. 74, Núm. 1, pp. 105-108

  2. COVID-19 and the impact of arterial hypertension—An analysis of the international HOPE COVID-19 Registry (Italy-Spain-Germany)

    European Journal of Clinical Investigation, Vol. 51, Núm. 11

  3. Does there exist an obesity paradox in COVID-19? Insights of the international HOPE-COVID-19-registry

    Obesity Research and Clinical Practice, Vol. 15, Núm. 3, pp. 275-280

  4. Effect of COMBinAtion therapy with remote ischemic conditioning and exenatide on the Myocardial Infarct size: a two-by-two factorial randomized trial (COMBAT-MI)

    Basic Research in Cardiology, Vol. 116, Núm. 1

  5. Fast track triage for COVID-19 based on a population study: The soda score

    Preventive Medicine Reports, Vol. 21

  6. Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry

    Revista Espanola de Cardiologia, Vol. 74, Núm. 2, pp. 175-182

  7. Impact of morbid obesity and obesity phenotype on outcomes after transcatheter aortic valve replacement

    Journal of the American Heart Association, Vol. 10, Núm. 12

  8. Impact of significant paravalvular leaks after transcatheter aortic valve implantation on anaemia and mortality

    Heart, Vol. 107, Núm. 6, pp. 497-502

  9. Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19

    Cardiology journal, Vol. 28, Núm. 3, pp. 360-368

  10. Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry

    Internal and Emergency Medicine, Vol. 16, Núm. 4, pp. 957-966

  11. Prognostic Impact of Change in Nutritional Risk on Mortality and Heart Failure After Transcatheter Aortic Valve Replacement

    Circulation. Cardiovascular interventions, Vol. 14, Núm. 2, pp. e009342